The Op2Lysis team wishes you a great and successful year 2021. We keep the pace to progress in the development of O2L-001 and to ensure the human / financials & technical ressources to treat our first ICH patients within 18 months.
Jérôme PARCQ administrator
————————- Our team ————————-
“Our ambition is to become a leader in research and development for stroke.”